NEW ENGLAND PEDIATRIC ONCOLOGY CONSORTIUM

新英格兰儿科肿瘤学联盟

• 批准号: 6137397
• 负责人: EDWIN N FORMAN
• 金额: $ 6.99万
• 依托单位: RHODE ISLAND HOSPITAL
• 依托单位国家: 美国
• 财政年份: 1981
• 资助国家: 美国
• 起止时间: 1981-01-01 至 2002-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6137397
• 关键词: 6 thiopurine; Ewing's tumor; Hodgkin's disease; Wilms' tumor; XomaZyme; acivicin; acute leukemia; acute lymphocytic leukemia; acute myelogenous leukemia; adolescence (12-20); antineoplastics; asparaginase; astrocytoma; biological response modifiers; bone marrow transplantation; brain neoplasms; cancer registry /resource; cancer risk; central nervous system neoplasms; child (0-11); chronic myelogenous leukemia; cis platinum compound; clinical research; clinical trial phase I; colony stimulating factor; combination cancer therapy; combination chemotherapy; cooperative study; cyclophosphamide; cyclosporines; cytosine arabinoside; daunorubicin; deferoxamine; deoxycoformycin; doxorubicin; drug screening /evaluation; enalapril; ependymoma; etoposide; fazarabine; fluorouracil; germ cell neoplasms; glioma; hepatoblastoma; hepatocellular carcinoma; human genetic material tag; human immunodeficiency virus 1; human subject; human therapy evaluation; human tissue; ifosfamide; interferons; interleukin 2; medulloblastoma; melphalan; metastasis; methotrexate; mitoxantrone; molecular oncology; neoplasm /cancer chemotherapy; neoplasm /cancer classification /staging; neoplasm /cancer epidemiology; neoplasm /cancer genetics; neoplasm /cancer immunology; neoplasm /cancer immunotherapy; neoplasm /cancer pharmacology; neoplasm /cancer radiation therapy; neoplasm /cancer relapse /recurrence; neoplasm /cancer surgery; neuroblastoma; nonHodgkin's lymphoma; osteosarcoma; paclitaxel; pediatric pharmacology; podophyllin; prednisone; retinoate; rhabdomyosarcoma; tissue resource /registry; topotecan; trimetrexate; vincristine

The specific aims of the New England Pediatric Oncology Consortium (NEPOC) are: Development and enhanced productivity of a consortium of regional pediatric cancer centers (Brown University/Rhode Island Hospital; Dartmouth University/Dartmouth-Hitchcock Medical Center; Harvard University/Massachusetts General Hospital; SUNY at Stony Brook/Children's Medical Center at Stony Brook; University of Vermont/Medical Center Hospital-Vermont Regional Cancer Center) for the purposes of: A. Contributing to the understanding and treatment of children and adolescents with malignancies through: 1. Input into national cooperative studies through membership in the Pediatric Oncology Group (POG): a. Patient accrual: Achieve significant number and quality of patient entries on protocols; b. Study development and evaluation: Assist in the development of new protocols through committee memberships, institutional reviews of proposed protocol designs, analysis of study results, and proposal of new protocols for POG implementation based on NEPOC studies; c. Administration: Accept responsibilities for POG administrative functions. 2. Cooperative efforts within NEPOC (New England Pediatric Oncology Consortium) in studies of joint interest in the areas of childhood malignancies, particularly toward developing potential pilot studies for POG. B. Enhancement of the care of children and adolescents with cancer in the geographical areas served by the member institutions through: 1. Assuring comprehensive and modern management of children and adolescents with malignancies as a benefit of membership in POG; 2. Sharing staff expertise and investigative facilities at each of the member institutions; 3. Joint efforts in promotion of education of the local community in the area of cancer in children and adolescents. Through a centralized administration, this Consortium integrates the activities and resources (staff, facilities, patients) at each institution into a single program aimed at achieving these goals.

新英格兰儿科肿瘤学联盟的具体目标 （NEPOC）的主要目标是： 地区儿科癌症中心（布朗大学/罗得岛 达特茅斯大学/达特茅斯-希区柯克医学中心; 哈佛大学/马萨诸塞州总医院;纽约州立大学斯托尼分校 布鲁克/斯托尼布鲁克儿童医学中心 佛蒙特州/医疗中心医院-佛蒙特州区域癌症中心） 目的： A.有助于理解和对待儿童， 患有恶性肿瘤的青少年： 1.通过参加国家合作研究， 儿科肿瘤组（POG）： a.患者增加：实现显著的患者数量和质量 协议条目; B.研究开发和评价：协助开发新的 通过委员会成员资格、机构审查 拟定的方案设计、研究结果分析以及新的 在国家环境业务中心研究的基础上，制定关于实施POG的议定书; C.行政：负责POG的行政管理 功能协调发展的 2. NEPOC（新英格兰儿科肿瘤学）内部的合作努力 在儿童领域共同感兴趣的研究中， 恶性肿瘤，特别是发展潜在的试点研究， POG。 B。加强对儿童和青少年癌症患者的护理， 成员机构通过以下方式服务的地理区域： 1.确保对儿童进行全面和现代化的管理， 患有恶性肿瘤的青少年作为POG成员的福利; 2.在每个国家分享工作人员的专门知识和调查设施 成员机构; 3.共同努力，促进当地社区的教育， 儿童和青少年的癌症领域。 通过集中管理，该联盟将 活动和资源（工作人员、设施、患者） 一个单一的计划，旨在实现这些目标。